DIAPH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.062400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.460600E-01
Normal-vs-Stage2
5.712200E-01
Normal-vs-Stage3
7.513800E-01
Normal-vs-Stage4
6.620200E-01
Stage1-vs-Stage2
3.229800E-01
Stage1-vs-Stage3
7.430400E-01
Stage1-vs-Stage4
5.306400E-01
Stage2-vs-Stage3
2.086200E-01
Stage2-vs-Stage4
7.808800E-01
Stage3-vs-Stage4
5.756800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.351400E-01
Normal-vs-AfricanAmerican
8.378000E-01
Normal-vs-Asian
5.902600E-01
Caucasian-vs-AfricanAmerican
9.853000E-01
Caucasian-vs-Asian
5.172000E-01
AfricanAmerican-vs-Asian
7.073200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.315600E-01
Normal-vs-Female
8.247400E-01
Male-vs-Female
2.640600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.338800E-01
Normal-vs-Age(41-60Yrs)
4.404000E-01
Normal-vs-Age(61-80Yrs)
8.598000E-01
Normal-vs-Age(81-100Yrs)
7.609600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.093400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.630000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.794200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.201800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.258400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.654000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.708000E-01
Normal-vs-Daily Drinker
7.201400E-01
Normal-vs-Weekly Drinker
9.169600E-01
Normal-vs-Occasional Drinker
6.906000E-01
Normal-vs-Social Drinker
7.542800E-01
Non Drinker-vs-Daily Drinker
8.212800E-01
Non Drinker-vs-Weekly Drinker
5.430400E-01
Non Drinker-vs-Occasional Drinker
7.276800E-01
Non Drinker-vs-Social Drinker
5.515000E-01
Daily Drinker-vs-Weekly Drinker
6.682000E-01
Daily Drinker-vs-Occasional Drinker
9.001400E-01
Daily Drinker-vs-Social Drinker
7.573600E-01
Weekly Drinker-vs-Occasional Drinker
7.189200E-01
Weekly Drinker-vs-Social Drinker
8.554200E-01
Occasional Drinker-vs-Social Drinker
8.222400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.285820E-01
Normal-vs-Grade 2
4.276500E-03
Normal-vs-Grade 3
3.824000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.830300E-04
Grade 1-vs-Grade 3
7.572600E-04
Grade 1-vs-Grade 4
1.285820E-01
Grade 2-vs-Grade 3
8.043600E-01
Grade 2-vs-Grade 4
4.276500E-03
Grade 3-vs-Grade 4
3.824000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.649600E-01
Normal-vs-NonDiabetic
6.667800E-01
Diabetic-vs-NonDiabetic
7.188400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.830000E-01
Normal-vs-NoPancreatitis
7.527800E-01
Pancreatitis-vs-NoPancreatitis
4.366200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.924200E-01
Normal-vs-N1
6.749400E-01
N0-vs-N1
9.807200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.369950E-01
Normal-vs-TP53-NonMutant
9.857400E-01
TP53-Mutant-vs-TP53-NonMutant
1.51546999999086E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
